Experimental Drug Shows Promise for Certain Breast Cancers
SUNDAY, June 3 (HealthDay News) — An experimental drug designed to treat patients with a specific kind of breast cancer known as HER2-positive appeared to boost survival compared to the standard treatment, a new study shows.